[Federal Register: September 29, 2006 (Volume 71, Number 189)]
[Notices]
[Page 57569-57570]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29se06-124]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated May 9, 2006, and published in the Federal Register
on May 15, 2006, (71 FR 28052), Johnson Matthey Inc., Custom
Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey
08066, made application by letter to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in Schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Dihydrocodeine (9120)...................... II
Oxymorphone (9652)......................... II
------------------------------------------------------------------------
The company plans to manufacture in bulk for distribution to its
customers, who are final dosage manufacturers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Johnson Matthey Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Johnson Matthey Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical
[[Page 57570]]
security systems, verification of the company's compliance with State
and local laws, and a review of the company's background and history.
Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR
1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: September 20, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-16023 Filed 9-28-06; 8:45 am]
BILLING CODE 4410-09-P